SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-023676
Filing Date
2023-04-06
Accepted
2023-04-06 20:32:07
Documents
1
Period of Report
2023-04-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4122
  Complete submission text file 0001209191-23-023676.txt   5491
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 720-647-8519
Enliven Therapeutics, Inc. (Issuer) CIK: 0001672619 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Collins Helen Louise (Reporting) CIK: 0001701247 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39247 | Film No.: 23807564